MRNA financials
Moderna (MRNA) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
- MRNA revenue was $1.94B in fiscal 2025, net income -$2.82B.
MRNA income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $1.94B | $1.08B | -$3.07B | -$2.82B | -7.26 |
| 2024 | $3.24B | $1.77B | -$3.94B | -$3.56B | -9.28 |
| 2023 | $6.85B | $2.15B | -$4.24B | -$4.71B | -12.33 |
| 2022 | $19.26B | $13.85B | $9.42B | $8.36B | 20.12 |
| 2021 | $18.47B | $15.85B | $13.30B | $12.20B | 28.29 |
| 2020 | $803.00M | $795.00M | -$763.00M | -$747.00M | -1.96 |